Cargando…

Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review

Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic manifestation of metabolic syndromes, and its roots are strongly associated with obesity and insulin resistance. The excess fat induces inflammatory pathways by tissue irritation and progresses to non-alcoholic steatohepatitis (NAS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaqub, Sayma, Ananias, Patricia, Shah, Arpita, Luenam, Kanita, Jose, Arunima Mariya, Melo, Joao Pedro, Turkistani, Arifa, Mohammed, Lubna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544702/ https://www.ncbi.nlm.nih.gov/pubmed/34722019 http://dx.doi.org/10.7759/cureus.18201

Ejemplares similares

Effectiveness of Manual Therapy and Acupuncture in Tension-Type Headache: A Systematic Review
por: Turkistani, Arifa, et al.
Publicado: (2021)

Cesarean Section: A Potential and Forgotten Risk for Abdominal Wall Endometriosis
por: Ananias, Patricia, et al.
Publicado: (2021)

Workup and Management of Recurrent Attacks of Post-bariatric Hypoglycemia in a Patient With Non-alcoholic Steatohepatitis
por: Pokhriyal, Sindhu C, et al.
Publicado: (2023)

Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Non-Alcoholic Steatohepatitis: A Clinical Review Article
por: Ghazanfar, Haider, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus
por: Padda, Jaskamal, et al.
Publicado: (2021)

Macro-aspartate Aminotransferase: Misleading Finding in a Patient with Non-alcoholic Fatty Liver Disease
por: Sharma, Neha, et al.
Publicado: (2019)

The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC)
por: Venniyoor, Ajit, et al.
Publicado: (2021)

Advancements in Diagnostic and Therapeutic Interventions of Non-alcoholic Fatty Liver Disease: A Literature Review
por: Chaudhry, Ahtshamullah, et al.
Publicado: (2023)

Elevated Liver Enzymes in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease
por: Mandal, Amrendra, et al.
Publicado: (2018)

Unraveling the Role of Hypothyroidism in Non-alcoholic Fatty Liver Disease Pathogenesis: Correlations, Conflicts, and the Current Stand
por: Gor, Rajvi, et al.
Publicado: (2021)

The Prospect of Non-Alcoholic Fatty Liver Disease in Adult Patients with Metabolic Syndrome: A Systematic Review
por: Zohara, Zareen, et al.
Publicado: (2023)

Ketogenic Diet-induced Elevated Cholesterol, Elevated Liver Enzymes and Potential Non-alcoholic Fatty Liver Disease
por: Anekwe, Chika V, et al.
Publicado: (2020)

The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease
por: Pokharel, Arbinda, et al.
Publicado: (2021)

Insulinoma in Patient With Nonalcoholic Steatohepatitis
por: Cain, Daniel, et al.
Publicado: (2023)

Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
por: Vonghia, Luisa, et al.
Publicado: (2013)

The Pathophysiology of Type 2 Diabetes Mellitus in Non-obese Individuals: An Overview of the Current Understanding
por: Olaogun, Idowu, et al.
Publicado: (2020)

MON-673 Use of Metabolic Syndrome Severity to Assess Treatment with Vitamin-E and Pioglitazone for Non-Alcoholic Steatohepatitis
por: DeBoer, Mark Daniel, et al.
Publicado: (2020)

Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
por: Kumari, Bandana, et al.
Publicado: (2021)

Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
por: Luci, Carmelo, et al.
Publicado: (2020)

Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway
por: Liu, Yu, et al.
Publicado: (2021)

A Case of Autoimmune Pancreatitis Presenting As Alcohol-Induced Necrotizing Pancreatitis
por: Creech, Zachary A, et al.
Publicado: (2023)

Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Iravani, Farzaneh, et al.
Publicado: (2018)

Association of Metabolic Dysfunction-Associated Steatotic Liver Disease/Non-alcoholic Fatty Liver Disease With Type 2 Diabetes Mellitus: A Case-Control Study in a Tertiary Care Hospital in Pakistan
por: Zahoor, Faizan, et al.
Publicado: (2023)

A Retrospective Study to Examine the Correlation of Bioelectrical Impedance Analysis with Shear-wave Elastography in Indian Patients with Non-alcoholic Fatty Liver Disease and Diabetes on Background Sodium-glucose Cotransporter-2 Inhibitor Therapy
por: Roy, Sayak, et al.
Publicado: (2019)

FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
por: Tillman, Erik J., et al.
Publicado: (2020)

The Influence of Insulin Resistance on Outcomes in Hospitalizations for Alcohol-Related Liver Disease: A Nationwide Study
por: Okpujie, Victory, et al.
Publicado: (2023)

Chronic Alcohol Abuse-Induced Hypokalemia Might Lead to Delayed Diagnosis or Misdiagnosis of Thyrotoxic Periodic Paralysis
por: Lin, Yan-Yu, et al.
Publicado: (2021)

Thyrotoxic Periodic Paralysis With Severe Hypokalemia Precipitated by Acute Alcohol Intoxication in a Patient With Graves’ Disease
por: Batra, Jaskaran, et al.
Publicado: (2023)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management
por: Habas, Elmukhtar, et al.
Publicado: (2021)

Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis
por: Dennis, Andrea, et al.
Publicado: (2021)

Transcriptomic changes in liver transplant recipients with non-alcoholic steatohepatitis indicate dysregulation of wound healing
por: Pellegrina, Diogo, et al.
Publicado: (2023)

Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology
por: Akter, Sharmin
Publicado: (2022)

Clinical Management of Nonalcoholic Steatohepatitis (NASH) With the Use of Thiazolidinediones and the Additive Effect of Thiazolidinediones and a GLP-1 Agonist: Case Series
por: Rojas Ortiz, Valentina, et al.
Publicado: (2021)

Pathophysiology, Diagnostic Criteria, and Approaches to Type 2 Diabetes Remission
por: Khamis, Abeer M
Publicado: (2023)

Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib
por: Jafri, Sabih, et al.
Publicado: (2021)

Calcium-Alkali Syndrome: Historical Review, Pathophysiology and Post-Modern Update
por: Zayed, Randa F, et al.
Publicado: (2021)

Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association
por: Shetty, Chaitra, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology
por: Memaj, Plator, et al.
Publicado: (2022)

Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Ahsan, Farah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_maqeu5rhol1vlsjr66g2vf9a8b